SCHEMBL5899564

SCHEMBL5899564

O=C(CN(CC(=O)c1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.51
TAS2R14 Q9NYV8 5/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPK1 P28482 3/20 0.49
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
CES1 P23141 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899440 0.89 TAS2R14 (0.63) HSD11B1TAS2R14MEN1KMT2AALDH1A1
SCHEMBL5899445 0.82 TAS2R14 (0.66) TAS2R14MEN1KMT2AALDH1A1MAPT
SCHEMBL5899607 0.82 HSD11B1 (0.57) HSD11B1MEN1KMT2AMAPK1ALDH1A1
SCHEMBL5899442 0.79 PTPN1 (0.57) HSD11B1TAS2R14MEN1KMT2AKEAP1
SCHEMBL5899551 0.76 TAS2R14 (0.56) TAS2R14MEN1KMT2AALDH1A1MAPT
SCHEMBL11802279 0.76 MAPK1 (0.71) MAPK1ALDH1A1KEAP1NFE2L2MMP1
SCHEMBL11324196 0.75 MMP1 (0.52) MEN1KMT2AMAPK1ALDH1A1KDM4E
SCHEMBL27614871 0.75 ALDH1A1 (0.50) HSD11B1MEN1KMT2AMAPK1ALDH1A1
SCHEMBL14145796 0.75 RECQL (0.60) HSD11B1TAS2R14MEN1KMT2AALDH1A1
SCHEMBL6347967 0.74 MMP9 (0.56) HSD11B1MMP1MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885TAS2R14 4454/4885MEN1 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.